It is proposed to participate in Immunefi’s upcoming bug bounty protocol launch, and earmark 100,000 DAI from the Funding subDAO for this opportunity to serve as a bounty.
Immunefi has been supporting mStable’s bug bounty program for more than 6 months, and is now upgrading its core product offering to include tokenized protocol governance and a more capital efficient way to use these bounties.
mStable would therefore like to participate in this new bug bounty product offering and allocate the above mentioned DAI to be put in escrow and have custodied by Immunefi.
The underlying collateral will then be used to generate yield, and in case of a found vulnerability, be used to reimburse the bug reporter.
Should mStable participate in Immunefi's upcoming bug bounty protocol launch, and allocate 100,000 DAI as specified in TDP 27?